Home

DAVID C DVORAK

CIK 1239000 · President and CEO · last filed 2017-05-01

DAVID C DVORAK is a President and CEO who has filed 47 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ZBH, was dated May 1, 2017. Across all open-market trades the lifetime net is −$38.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $35.7M across reported positions. 50 SEC filings were submitted jointly with ZIMMER BIOMET HOLDINGS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$35.70M

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$38.83M

Filer Profile

Reported Address
C/O ZIMMER INC
PO BOX 708
WARSAW, IN 46580
Related Filers
ZIMMER BIOMET HOLDINGS, INC. — 50 joint filings, latest 2017-05-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZBH President and CEO 381,886 $93.49 $35.70M -$38.83M 43 2017-05-01
ST JUDE MEDICAL, LLC (STJ) Delisted Director 5,599 — — $0 3 2016-06-03

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-05-01 ZBH Mixed +12,669 -$1.30M EDGAR
2017-03-23 ZBH Grant (A) — $0 EDGAR
2017-03-21 ZBH Mixed +11,738 -$1.47M EDGAR
2017-02-13 ZBH Grant (A) — $0 EDGAR
2017-02-06 ZBH Mixed +9,293 -$695.4K EDGAR
2017-01-06 — Disp (D) −5,599 $0
2016-06-03 ST JUDE MEDICAL, LLC (STJ) Delisted Grant (A) +1,277 $100.0K EDGAR
2016-05-06 ST JUDE MEDICAL, LLC (STJ) Delisted Grant (A) +2,401 $180.9K EDGAR
2016-03-23 ZBH Grant (A) — $0 EDGAR
2016-03-22 ZBH Mixed +15,980 -$1.75M EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.